<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for OMER</title>
    <link />
    <description>Headlines for Omeros</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Traders in Omeros Attributing Upside in Shares to Bullish Note from MLV &amp; Co., Says Trend Higher 'Wi</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/05/3589052/traders-in-omeros-attributing-upside-in-shares-to-bullis.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 14 May 2013 15:58:11 GMT</pubDate>
    </item>
    <item>
      <title>Short Interest Jumps 41.2% For OMER</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11920453/1/short-interest-jumps-412-for-omer.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Fri, 10 May 2013 15:32:00 GMT</pubDate>
    </item>
    <item>
      <title>Omeros Announces 3.9M Share Direct Offering of Common Stock at $4.14/Share</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3577592/omeros-announces-3-9m-share-direct-offering-of-common-stock-at-4-14share.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 09 May 2013 19:31:33 GMT</pubDate>
    </item>
    <item>
      <title>Omeros' OMS721 Files for Orphan Drug Status - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97391/omeros-oms721-files-for-orphan-drug-status.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 18 Apr 2013 17:00:01 GMT</pubDate>
    </item>
    <item>
      <title>WBB Pounds the Table on Omeros Following Orphan Drug Status, Maintains Strong Buy Rating, $20 Target</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3509196/wbb-pounds-the-table-on-omeros-following-orphan-drug-status-maintains-strong-buy-.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 18 Apr 2013 14:11:40 GMT</pubDate>
    </item>
    <item>
      <title>Omeros Files Orphan Drug Application with FDA for OMS721</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3503399/omeros-files-orphan-drug-application-with-fda-for-oms721.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 17 Apr 2013 07:11:56 GMT</pubDate>
    </item>
    <item>
      <title>Omeros Announces Positive Data for Model for Studying Multiple Sclerosis</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/earnings/13/04/3485232/omeros-announces-positive-data-for-model-for-studying-multiple-sclerosis.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 10 Apr 2013 07:05:52 GMT</pubDate>
    </item>
    <item>
      <title>Omeros: Whittling In Walcott's Shadow</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1327021-omeros-whittling-in-walcott-s-shadow.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 08 Apr 2013 10:29:21 GMT</pubDate>
    </item>
    <item>
      <title>Omeros Announces Positive OMS721 Data</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3463174/omeros-announces-positive-oms721-data.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 02 Apr 2013 07:08:02 GMT</pubDate>
    </item>
    <item>
      <title>Omeros Progresses with OMS824 - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/95907/omeros-progresses-with-oms824.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 28 Mar 2013 18:40:01 GMT</pubDate>
    </item>
    <item>
      <title>A Peek Into The Market Before The Trading Starts</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3454014/a-peek-into-the-market-before-the-trading-starts.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 28 Mar 2013 07:45:39 GMT</pubDate>
    </item>
    <item>
      <title>Omeros Announces Toxicology Data from OMS721 Study Support Advancing MASP-2 Inhibitor into Clinical</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3453887/omeros-announces-toxicology-data-from-oms721-study-support-advancing-masp-2-inhib.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 28 Mar 2013 07:14:11 GMT</pubDate>
    </item>
    <item>
      <title>Stocks Hitting 52-Week Lows</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3447298/stocks-hitting-52-week-lows.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 26 Mar 2013 10:51:39 GMT</pubDate>
    </item>
    <item>
      <title>Omeros Completes PDE10 Phase 1 Multiple Ascending Dose Trial</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3446030/omeros-completes-pde10-phase-1-multiple-ascending-dose-trial.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 26 Mar 2013 07:06:08 GMT</pubDate>
    </item>
    <item>
      <title>Stocks Hitting 52-Week Lows</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3436333/stocks-hitting-52-week-lows.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 21 Mar 2013 10:43:00 GMT</pubDate>
    </item>
    <item>
      <title>Omeros Doesn't Look Like That Much Of An Opportunity</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1267221-omeros-doesn-t-look-like-that-much-of-an-opportunity.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 13 Mar 2013 15:09:33 GMT</pubDate>
    </item>
    <item>
      <title>Omeros Corporation's Stock Has Potential To Double This Year</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1200161-omeros-corporation-s-stock-has-potential-to-double-this-year.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 18 Feb 2013 05:55:10 GMT</pubDate>
    </item>
    <item>
      <title>Omeros May Be A Wonderful, Albeit Speculative, Biopharmaceutical Opportunity</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1160991-omeros-may-be-a-wonderful-albeit-speculative-biopharmaceutical-opportunity.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 06 Feb 2013 13:41:35 GMT</pubDate>
    </item>
    <item>
      <title>Maxim Group Sees 350% Upside In Shares Of Omeros Corporation</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1153471-maxim-group-sees-350-upside-in-shares-of-omeros-corporation.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 04 Feb 2013 03:29:00 GMT</pubDate>
    </item>
    <item>
      <title>Safety Data on Omeros' OMS302 - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/91085/safety-data-on-omeros-oms302.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 23 Jan 2013 17:20:01 GMT</pubDate>
    </item>
  </channel>
</rss>
